Lorlatinib clinical trial recruitment conditions in China

The conditions of clinical trials are usually determined by the host institution and sponsor of the trial, and this information is usually published on specialized clinical trial registration platforms, medical journals, or the official websites of medical research institutions.

Generally speaking, conditions for recruitment into clinical trials may include the following:

1.Patient Characteristics: Trials may target specific types of patients, such as patients with non-small cell lung cancer (NSCLC) who have specific genotypes or who are resistant to other treatment options. These patient characteristics may involve age, gender, disease stage, etc.

2.Health status: Trials often specify a patient's overall health to ensure they are suitable to participate in the trial. This may include some physiological indicators such as liver function, kidney function, etc., as well as some clinical assessments.

3.Treatment history: The patient's treatment history may be specified, such as whether he has received related targeted therapy or chemotherapy before, and whether he has developed resistance to these treatment regimens.

4.Other inclusion and exclusion criteria: The trial may also specify some other inclusion and exclusion criteria, such as whether the patient suffers from other serious diseases, is pregnant or breastfeeding, etc.

To obtain the specific recruitment clinical trial conditions of lorlatinib in China, it is recommended that you visit the China National Medical Products Administration (NMPA)'s official website, professional clinical trial registration platform, or contact relevant medical research institutions and hospitals. At the same time, you can also consult relevant medical literature and scientific journals to obtain the latest research trends and trial information.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.